Ascorbic acid in Charcot—Marie—Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial The Lancet Neurology, 04/05/2011

Pareyson D et al. – Ascorbic acid supplementation had no significant effect on neuropathy compared with placebo after 2 years, suggesting that no evidence is available to support treatment with ascorbic acid in adults with Charcot—Marie—Tooth disease type 1AV

Read this article on The Lancet Neurology


The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List